Unigef 250mg Tablet 10s

Introduction to Unigef 250mg Tablet 10s

Unigef 250mg Tablet 10s is a medication primarily used to treat a specific type of lung cancer known as non-small cell lung cancer (NSCLC). It is particularly effective for patients with certain gene mutations called EGFR mutations. This medicine is often prescribed to patients who have not undergone chemotherapy before.

Composition of Unigef 250mg Tablet 10s

The active ingredient in Unigef 250mg Tablet is Gefitinib, which is an EGFR tyrosine kinase inhibitor. This means it works by blocking signals that promote cancer cell growth, specifically targeting mutated EGFR receptors.

Uses of Unigef 250mg Tablet 10s

• Treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC).
• Specifically targets cancer with EGFR mutations.
• Prescribed for patients who have not received prior chemotherapy.

Side effects of Unigef 250mg Tablet 10s

Common side effects:

• Diarrhea
• Skin rash
• Nausea
• Vomiting
• Loss of appetite

Serious side effects:

• Liver toxicity
• Lung inflammation
• Severe diarrhea leading to dehydration

Precautions of Unigef 250mg Tablet 10s

Unigef should not be taken by individuals without EGFR mutations, pregnant or breastfeeding women, or those with severe liver or kidney disease. It is also contraindicated for patients with a history of interstitial lung disease or those allergic to Gefitinib or any of its ingredients.

How to Take Unigef 250mg Tablet 10s

• Take one tablet orally once daily.
• It is best to take the tablet at the same time each day.
• Swallow the tablet whole with water; do not crush or chew.

Conclusion of Unigef 250mg Tablet 10s

Unigef 250mg Tablet 10s is a targeted therapy for non-small cell lung cancer with EGFR mutations. It is crucial to follow your healthcare provider's instructions and report any side effects. Always consult your doctor before starting or stopping this medication.